Tyra Biosciences Inc

Market Cap

$2B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$26.75-$0.04 (-0.15%)

Jun 8, 2026

52W High $39.6152W Low $9.10

Company Details

Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug...

CEO

—

IPO Date

Sep 15, 2021

Website

tyra.bio

Key Metrics TTM

Revenue

-100.0% YoY

Net Income

-$131M

EPS (Diluted)

Free Cash Flow

-$102M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q1 2026

May 13, 2026

FY 2025

Mar 2, 2026

Q4 2025

Mar 2, 2026

$0-100.0%

Q3 2025

Nov 5, 2025

Q2 2025

Aug 14, 2025

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee